US 7622467
Aryl aniline derivatives as β2 adrenergic receptor agonists
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7622467 (Aryl aniline derivatives as β2 adrenergic receptor agonists) held by Theravance, Inc. expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P43/00